Developing ANDI: a novel approach to health product R&D in Africa
about
The Chemistry and Biological Activities of Natural Products from Northern African Plant Families: From Taccaceae to ZygophyllaceaeTraditional medicines as a mechanism for driving research innovation in AfricaInnovative partnerships for drug discovery against neglected diseasesIntegrated dataset of screening hits against multiple neglected disease pathogensUse of data from registered clinical trials to identify gaps in health research and developmentBiomedical research, a tool to address the health issues that affect African populations.A look at the ASEAN-NDI: building a regional health R&D innovation networkRegistering new drugs for low-income countries: the African challenge.A call for using natural compounds in the development of new antimalarial treatments - an introduction.Understanding the state of health policy and systems research in West Africa and capacity strengthening needs: scoping of peer-reviewed publications trends and patterns 1990-2015.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent.Science-based health innovation in sub-Saharan Africa.The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.Venture funding for science-based African health innovationStrengthening research capacity--TDR's evolving experience in low- and middle-income countriesIncreasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysisMentoring, training and support to global health innovators: a scoping review.The West African Health Organization's experience in improving the health research environment in the ECOWAS region.Technology innovation for infectious diseases in the developing world.The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.The potential of anti-malarial compounds derived from African medicinal plants, part I: a pharmacological evaluation of alkaloids and terpenoids.Do Students Eventually Get to Publish their Research Findings? The Case of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Research in Cameroon.Global health. Stagnant health technologies in Africa.Challenges and opportunities for chemistry in Africa.Africa's leadership in biomedical research: Shifting the center of gravity.The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discoveryThe uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classesThe uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy
P2860
Q26765143-42FC41C9-A2A2-4E1F-8AD0-16CBA1E249F2Q27690713-8233BC63-6FA2-45A2-A080-6F305853E3FBQ28477241-65579C89-BD8E-48BC-8676-5FD55F087D8DQ28478485-AA478163-2E2D-4031-B23B-47834162F5C4Q30668525-3E0BB32F-C134-4335-AA46-F42F7D474A07Q33589357-D2E629D1-E2B6-4250-A790-A030E38EC981Q33614672-FB7DDCE3-497B-4725-8F9E-660C30F7F72AQ33847338-96C8D1E6-E302-42FC-BA2B-849CB7315042Q33848637-57257CE2-EC95-4E9D-AB36-3D09C4AEFA84Q33917789-DF99160F-622B-4E8A-9232-6340910E8420Q34297640-76AE4796-9AEA-4002-B3EF-69C1218B3CE5Q34354153-E6355DB9-0FC9-409C-9179-382588D9D64CQ34404295-211F50FF-C806-447B-8E1A-49A062DF901DQ34404311-2E92976A-E8A3-4CB2-A0B4-9D8EC6600448Q34404317-20790029-3C2E-4886-8D60-05E42D6FE3E2Q34874737-024B1F72-E731-4FAE-97F2-CEEF1F8E0352Q35179927-03B6A71E-41D7-4610-8295-5F605F1370C4Q36647823-449CC2FC-B404-43AF-A82A-1EACAB451EE4Q36820291-99E998EC-DE4B-4CBF-A9E3-3D638DA7D458Q37008584-07E4033C-019B-41B4-98E2-979B2DFE2E3CQ37228107-EF2A8E0F-031E-4B1D-8B07-416DFFEFD8B8Q37427043-D1EC4A82-A0EB-402D-946B-454C6CA3136BQ38223770-81E955E8-76D2-4D34-84C8-F297155247F7Q39464384-514EC250-FA1C-4A10-B735-8DEE069DF422Q40792970-04E35D46-F3DD-4B55-B43D-93C2E1103A6AQ48316039-853C2C93-2DAD-4072-B572-DE45FFB22095Q58860062-09FCB178-55E4-48F9-94A3-5C891F7FC5FEQ58860064-438AB3CB-DE82-42C4-912E-A5F990715B20Q58860065-E9C36885-7BC7-4B1A-A63C-140365CE453A
P2860
Developing ANDI: a novel approach to health product R&D in Africa
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Developing ANDI: a novel approach to health product R&D in Africa
@ast
Developing ANDI: a novel approach to health product R&D in Africa
@en
type
label
Developing ANDI: a novel approach to health product R&D in Africa
@ast
Developing ANDI: a novel approach to health product R&D in Africa
@en
prefLabel
Developing ANDI: a novel approach to health product R&D in Africa
@ast
Developing ANDI: a novel approach to health product R&D in Africa
@en
P2093
P2860
P1433
P1476
Developing ANDI: a novel approach to health product R&D in Africa
@en
P2093
Doan Hackley
Emiliano Rial Verde
Jorge Santos Da Silva
Raymond De Vré
Robert G Ridley
Solomon Nwaka
Tom Mboya-Okeyo
Tshinko B Ilunga
P2860
P304
P356
10.1371/JOURNAL.PMED.1000293
P407
P577
2010-06-29T00:00:00Z